Crizotinib: prices and alternatives
Crizotinib is a kinase inhibitor indicated for adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are ALK-positive or ROS1-positive. It is also indicated for pediatric patients aged 1 year and older and young adults with relapsed or refractory systemic ALK-positive anaplastic large cell…
2 products with this active ingredient from 1 manufacturer. Official prices from 39384 to 70085 EGP.
Every box with this active ingredient, cheapest first.
Informational only — may be inaccurate or incomplete. Don't rely on it medically; verify with a pharmacist.

